the Oil Red O and BODPIY staining showed that in cholesterol-stimulated INS-1 cells, lipid droplet accumulation was markedly increased compared to that in the control group while it decreased after EX-4 treatment alone or cholesterol co-treatment compared with that in the single cholesterol group (Figure 1I)
All this means that there are differences between these compounds in terms of their potency in reducing HbA1c, baseline glycemia or weight reduction, among other factors, which should be considered when choosing drugs from this family.78,83,84 Cardiovascular protection of glucagon-like peptide type 1 receptor agonists Several randomized clinical trials have analyzed the cardiovascular safety of arGLP1 versus standard therapy
While patches are promising, its important to note that GLP-1 patches are still emerging in clinical trials and are not as widely available as injections
"GLP-1 Review 2026": Refers to this article's educational review of Omzo's published program details, pricing, refund terms, and regulatory context as of June 2026